Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | BIRC5 | O15392 | 1/20 | 0.33 |
| ▸ | EBP | Q15125 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | LTA4H | P09960 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13917443 | 0.86 | MEN1 (0.36) | MEN1POLBKMT2ABIRC5EBP | |
| SCHEMBL9897299 | 0.85 | HTR1B (0.36) | ALDH1A1 | |
| SCHEMBL13917432 | 0.81 | PLA2G1B (0.36) | MEN1POLBKMT2A | |
| SCHEMBL9897525 | 0.80 | MAPT (0.33) | — | |
| SCHEMBL9897825 | 0.78 | KDM4E (0.33) | KDM4EALDH1A1 | |
| SCHEMBL9898815 | 0.78 | KDM4E (0.33) | KDM4EALDH1A1 | |
| SCHEMBL320429 | 0.77 | TSHR (0.39) | ALDH1A1 | |
| SCHEMBL22186699 | 0.76 | ALDH1A1 (0.32) | KDM4EMEN1POLBKMT2AALDH1A1 | |
| SCHEMBL1132445 | 0.75 | TSHR (0.43) | CYP2D6ALDH1A1 | |
| SCHEMBL2141291 | 0.75 | SLC2A1 (0.37) | MEN1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9150595-B2 | Process for producing silane coupling agent | BRIDGESTONE CORPORATION (JP) | 2015-10-06 | — | — | US | claimed |
| EP-2471798-B1 | PROCESS FOR PRODUCTION OF SILANE COUPLING AGENTS | BRIDGESTONE CORP (JP) | 2015-08-19 | — | — | EP | claimed |
| EP-2471798-A1 | PROCESS FOR PRODUCTION OF SILANE COUPLING AGENTS | Bridgestone Corporation (JP) | 2012-07-04 | — | — | EP | claimed |
| US-20120149929-A1 | PROCESS FOR PRODUCING SILANE COUPLING AGENT | BRIDGESTONE CORPORATION (JP) | 2012-06-14 | — | — | US | claimed |
| US-9150595-B2 | Process for producing silane coupling agent | BRIDGESTONE CORPORATION (JP) | 2015-10-06 | — | — | US | disclosed |
| EP-2471798-B1 | PROCESS FOR PRODUCTION OF SILANE COUPLING AGENTS | BRIDGESTONE CORP (JP) | 2015-08-19 | — | — | EP | disclosed |
| EP-2471798-A1 | PROCESS FOR PRODUCTION OF SILANE COUPLING AGENTS | Bridgestone Corporation (JP) | 2012-07-04 | — | — | EP | disclosed |
| US-20120149929-A1 | PROCESS FOR PRODUCING SILANE COUPLING AGENT | BRIDGESTONE CORPORATION (JP) | 2012-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149929-A1 | PROCESS FOR PRODUCING SILANE COUPLING AGENT | HAO2, SAMM50, SKP2 | KDM4E 1334/4885MEN1 3207/4885POLB 1796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.